Emergent, a Contract Drug Manufacturer, is Waiting for the U.S. Food and Drug ... - Latest Tweet by Reuters

Emergent, a contract drug manufacturer, is waiting for the U.S. Food and Drug Administration to approve release of those doses.

The agency must still inspect and authorize the plant before Emergent can ship newly manufactured drug substance, one of the sources says 2/4 pic.twitter.com/antdwR2BEj— Reuters (@Reuters) October 28, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)